AbCellera Biologics Inc. announced that at its AGM held on June 13, 2024, the shareholders approved the election of Andrew Lo, Ph.D. as Class I directors of the company to serve for a three-year term expiring at the company?s annual meeting of shareholders in 2027 and until his or her successor has been elected and qualified.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.96 USD | +2.78% |
|
+0.68% | -48.16% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.16% | 847M | |
+38.65% | 39.1B | |
-8.62% | 38.76B | |
+26.95% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+44.87% | 14.06B | |
+34.36% | 13.12B | |
-7.14% | 11.32B | |
-12.61% | 10.68B |
- Stock Market
- Equities
- ABCL Stock
- News AbCellera Biologics Inc.
- AbCellera Biologics Inc. Approves Election of Andrew Lo as Class I Director